Overview: Cocaine Metabolite Screen TestIntroduction: The Cocaine Metabolite Screen Test detects cocaine use, indicating substance abuse causing agitation or heart issues. Following 2023 SAMHSA guidelines, it uses chromatography for high sensitivity, aiding in drug screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in toxicology for patients with suspected substance abuse.
Other Names: Cocaine Screen Assay, Drug Abuse Test.
FDA Status: Laboratory-developed test (LDT), meeting toxicology standards for diagnostic accuracy.
Historical Milestone: Cocaine testing began in the 1970s with drug abuse research. Chromatography methods emerged in the 1980s, and by the 2000s, gas chromatography-mass spectrometry improved detection accuracy.
Purpose: Detects cocaine use, guides substance abuse treatment, and monitors compliance in patients with agitation or heart issues.
Test Parameters: 1. Cocaine & Metabolites
Pretest Condition: No fasting required. Collect urine, serum, plasma, or hair at any time. Report symptoms like agitation or chest pain, and list medications.
Specimen: 5-20 mL urine (sterile container), 2-5 mL serum (SST), 2-4 mL plasma (EDTA), or 1-2 g hair (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document agitation, heart issues, or substance use history. Include current medications, especially psychotropics.
Consent: Written consent required, detailing the tests purpose, implications for substance abuse treatment, and potential legal or occupational consequences.
Procedural Considerations: Uses chromatography (e.g., GC-MS) to detect cocaine and metabolites. Results are available in 1-2 days, supporting rapid clinical decisions.
Factors Affecting Result Accuracy: Cross-reactivity with certain medications may cause false positives. Improper storage can degrade samples.
Clinical Significance: Positive results confirm cocaine use, prompting addiction treatment or monitoring. Negative results may require confirmatory testing.
Specialist Consultation: Consult a toxicologist for result interpretation. An addiction specialist referral is advised for treatment planning.
Additional Supporting Tests: Urine drug panel, blood alcohol test, or opioid screen to assess polysubstance use.
Test Limitations: False positives may occur with certain medications. Results require clinical correlation with history.
References: SAMHSA Drug Testing Guidelines, 2023; Journal of Analytical Toxicology, Moeller MR, 2022.
